Results 41 to 50 of about 6,753 (182)

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study

Avicenna Journal of Medicine, 2015
Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate
Niyazi Kilic, Özhan Özdemir, Hakan Cevdet Başar, Fadime Demircan, Fırat Ekmez, Oğuz Yücel   +5 more
doaj   +1 more source

Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment [PDF]

, 2021
D.D. Miceli, Patricia Vidal, Gustavo A Pompili, Víctor Castillo, Elber Alberto Soler Arias, Stijn Niessen   +5 more
openalex   +1 more source

Protective effect of rooming‐in on postpartum hemorrhage: A propensity score analysis

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 604-611, January 2026.
Abstract Objective This study investigates the effect of rooming‐in on postpartum hemorrhage (PPH) and other adverse maternal postpartum outcomes. Methods A retrospective study was performed on all healthy women with singleton term pregnancies at a tertiary medical center between 2013 and 2022.
Natav Hendin, Yossi Geron, Ran Matot, Shiran Loewenstein, Eran Hadar, Asnat Walfisch, Rony Chen, Ohad Houri   +7 more
wiley   +1 more source

Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model

Gynecological Endocrinology, 2022
Objective: Ovarian hyperstimulation syndrome is an iatrogenic condition that occurs in the treatment of infertility. There is no specific treatment available for OHSS.
Şükrü Bakırcı, Nevin Sağsöz, Tuba Devrim, Yaşar Şahin, Murat Bulanık, Hilal Gözüyukarı   +5 more
doaj   +1 more source

A validated LC–MS/MS method for analysis of Cabergoline in human plasma with its implementation in a bioequivalent study: investigation of method greenness [PDF]

, 2022
Khaled Shalaby, Saleh Alghamdi, Mohammed Gamal, Lobna Mohammed Abd Elhalim, Rehab Moussa Tony   +4 more
openalex   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome [PDF]

Iranian Journal of Medical Sciences, 2011
Type 2 receptors for vascular endothelial growth factor are believed to be involved in the pathophysiology of ovarian hyperstimulation syndrome (OHSS).
Marzieh Agha Hosseini, Ashraf Aleyasin, Atossa Mahdavi, Romina Nezami, Leila Safdarian   +4 more
doaj  

Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real‐World Health Claims Data

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose In April 2022, fertility treatments, including assisted reproductive technology (ART), became eligible for public health insurance coverage in Japan. This study describes the prevalence and characteristics of infertility diagnoses and fertility treatments during the first year of coverage.
Makoto Okawara, Tomoichiro Kuwazuru, Moe Masunaga, Kenji Fujimoto, Masako Nagata, Takeshi Iwasa, Yoshihisa Fujino   +6 more
wiley   +1 more source

Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review

International Journal of Women's Health, 2020
Yang Yang,1 Isabelle Boucoiran,2 Karen J Tulloch,3 Vanessa Poliquin4 1University of Manitoba, Winnipeg, MB, Canada; 2Department of Obstetrics & Gynecology, Université de Montréal, Montreal, QC, Canada; 3BC Women’s Hospital ...
Yang Y, Boucoiran I, Tulloch KJ, Poliquin V   +3 more
doaj  

Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
The graphical abstract for the stability of medicatioins administred via enteral feeding tube: A systematic review ((PROSPERO, registration number: CRD42024580820)). ABSTRACT Feeding tubes are essential for patients unable to maintain adequate oral intake, serving multiple purposes including nutrition delivery and medication administration.
Lena Alodat, Wejdan Shahin, Lina Breik, Ayman Allahham   +3 more
wiley   +1 more source